MEI Pharma, Inc. (MEIP) Financials
MEIP Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 78.5 million | 19.1 million |
2023-09-30 | 101.3 million | 19.9 million |
2023-06-30 | 120.8 million | 96.2 million |
2023-03-31 | 134.2 million | 99.8 million |
MEIP Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -11.1 million | 850000 |
2023-09-30 | -18.5 million | 363000 |
2023-06-30 | -11.3 million | 299000 |
2023-03-31 | -12.1 million | 918000 |
MEIP Net Income
No data available :(
MEIP Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 59.5 million | - | 12.0 million |
2023-09-30 | 82.2 million | - | 12.4 million |
2023-06-30 | 100.7 million | - | 12.7 million |
2023-03-31 | 112.0 million | - | 13.1 million |
MEIP Shares Outstanding
MEIP Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 7000 | 3.9 million | 8.0 million | -85000 |
2023-09-30 | 7000 | 3.5 million | 6.5 million | - |
2023-06-30 | 28000 | 2.6 million | 10.0 million | - |
2023-03-31 | 7000 | 15.1 million | 7.2 million | - |
MEIP Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 85000 |
2023-09-30 | 65.3 million | 459000 |
2023-06-30 | 1.5 million | 464000 |
2023-03-31 | 5.9 million | 457000 |
MEIP
Price: $3.06
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.98 USD
P/E Ratio: 0.74
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 480786
Ebitda: -6.2 millionMarket Capitalization: 21.7 million